StockViz
RANKINGS
AtriCure, Inc.
NasdaqGM:ATRC
Sector
Industries
Location
Market Cap
USD 1.53 B
Share Price
USD 30.82
Avg Daily Volume
556,966
Change (1 day)
4.94%
Change (1 year)
24.63%
Change (YTD)
0.85%
AtriCure, Inc. Income Statement 2015 - 2025
This table shows the Income Statement for AtriCure, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
Abbott Laboratories
USD 125.83
ABT
+0.10
0.08%
Intuitive Surgical, Inc.
USD 501.95
ISRG
-9.05
-1.77%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Stryker Corporation
USD 400.93
SYK
+5.78
1.46%
Danaher Corporation
USD 197.89
DHR
+7.98
4.20%
Medtronic plc
USD 92.01
MDT
+0.36
0.39%
Siemens Healthineers AG
USD 54.74
SHL.DE
+1.05
1.95%
Axon Enterprise, Inc.
USD 705.22
AXON
-15.52
-2.15%
Becton, Dickinson and Company
USD 182.58
BDX
+1.30
0.72%
Edwards Lifesciences Corporation
USD 76.91
EW
+0.61
0.80%
HOYA Corporation
USD 132.65
7741.T
+5.78
4.55%
IDEXX Laboratories, Inc.
USD 540.68
IDXX
+8.68
1.63%
AMETEK, Inc.
USD 181.28
AME
+2.08
1.16%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
USD 31.82
300760.SZ
-0.08
-0.26%
Cardinal Health, Inc.
USD 157.76
CAH
+0.66
0.42%
GE HealthCare Technologies Inc.
USD 77.25
GEHC
+0.76
0.99%
DexCom, Inc.
USD 86.43
DXCM
+1.31
1.54%
Agilent Technologies, Inc.
USD 119.47
A
+3.28
2.82%